Customize your experience
You decide what information you want to see on your Sanofi Campus
Explore the most popular scientific articles and videos among Campus Sanofi users
Stay up to date and register for the latest events and view webinar recordings
Dyslipidemia Webinars: Optimizing Dyslipidemia management
Support for your patients
Discover the selection of support materials for patients from different therapeutic areas
Sanofi in News
Discover headline news on how Sanofi is engaged with the medical community
Ministry of Health organizes "KiDS" program at Expo 2020 Dubai to promote diabetes awareness at schools
Sanofi signs multi-pronged partnership with Dasman Diabetes Institute to intensify diabetes prevention in Kuwait
Saudi Health Council, Sanofi partner to boost diabetes studies and research in the kingdom
Glimepiride is an orally active hypoglycaemic substance belonging to the sulfonylurea group. It may be used in non-insulin dependent diabetes mellitus.
Irbesartan is a potent, orally active, selective angiotensin-II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin-II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin-II used to Effectively control Hypertension to normal Rates.
AUBAGIO® is a once-daily oral tablet that is indicated for adult patients with relapsing remitting multiple sclerosis (RRMS)
Enoxaparin Sodium is a low molecular weight heparin (LMWH) that is administered subcutaneously and used as antithrombotic agent.
Is a fully human monoclonal antibody with multiple indications in different therapeutic areas.
Insulin Glargine 100, a long-acting insulin administered subcutaneously and used to treat diabetes mellitus in adults, adolescents and children from the age of 2 years.
Lemtrada® is a monoclonal antibody produced in mammalian cells (Chinese Hamster Ovary).
Clopidogrel is an inhibitor of platelet
aggregation administered orally and
indicated for Secondary prevention of
Combination of Insulin Glargine (a basal insulin analog) & Lixisenatide (a GLP-1 receptor agonist) administered subcutaneously.
Levofloxacin is used in adults for the treatment of infections. The dosage depends on the type and severity of the infection and the susceptibility of the presumed causative pathogen.
Insulin Glargine 300, a long-acting insulin administered subcutaneously and used to treat diabetes mellitus in adults, adolescents and children from the age of 6 years.
▼This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.
YOU WILL NOW BE LEAVING THE SITE
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.